Science Explorer Back to mapMap
Discussion
Topic · Oncology

Ear and Head Tumors

Ear and Head Tumors is a research topic within Oncology. Science Explorer counts 18k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on various types of tumors affecting the ear and temporal bone, including squamous cell carcinoma, endolymphatic sac tumors, middle ear adenomas, and carcinoid tumors. The papers discuss the clinical features, management outcomes, treatment strategies such as chemoradiotherapy and surgical resection, as well as the implications of von Hippel-Lindau disease on these tumors.

  • Ear Tumors
  • Temporal Bone Carcinoma
  • Squamous Cell Carcinoma
  • Endolymphatic Sac Tumors
  • von Hippel-Lindau Disease
  • Middle Ear Adenoma
  • Carcinoid Tumor
  • Chemoradiotherapy
  • Surgical Management
  • Metastases
Research works
18k
fractional, since 1950
In the world top 10%
1.8k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-4%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Ear and Head Tumors

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ear and Head Tumors research?

By volume, the United States and India publish the most (543 and 364 works in 2022-now).

By volume, 2022-now

  1. 1 United States 543 works
  2. 2 India 364 works
  3. 3 China 300 works
  4. 4 Japan 251 works
  5. 5 Germany 123 works
  6. 6 Italy 99 works
  7. 7 United Kingdom 74 works
  8. 8 South Korea 72 works
  9. 9 Brazil 65 works
  10. 10 Türkiye 62 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.8%India: 18.7%China: 15.4%Japan: 12.8%6 others listed: 25.3%28%largest
United States543 · 27.8%India364 · 18.7%China300 · 15.4%Japan251 · 12.8%6 others listed494 · 25.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ear and Head Tumors research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Ear and Head Tumors research, followed by Harvard University and Mayo Clinic.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 36 works
  2. 2 Harvard UniversityUnited States 21 works
  3. 3 Mayo ClinicUnited States 20 works
  4. 4 Fudan UniversityChina 20 works
  5. 5 Capital Medical UniversityChina 17 works
  6. 6 The University of Texas MD Anderson Cancer CenterUnited States 14 works
  7. 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
  8. 8 Shanghai Jiao Tong UniversityChina 13 works
  9. 9 Banaras Hindu UniversityIndia 12 works
  10. 10 The Ohio State UniversityUnited States 10 works

Who are the leading researchers in Ear and Head Tumors?

The most-cited researchers publishing on Ear and Head Tumors include Kai You Wang, Marc Ladanyi and Ralph H. Hruban.

  1. 1 Kai You Wang China 224k citations
  2. 2 Marc Ladanyi United States 217k citations
  3. 3 Ralph H. Hruban United States 209k citations
  4. 4 Michael R. Stratton United Kingdom 203k citations
  5. 5 Nikolaus D. Schultz United States 200k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ear and Head Tumors?

The most cited paper in Ear and Head Tumors is "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma" (Stephen Henry Friend, René Bernards, Snezna Rogelj et al., 1986), with 2,994 citations. Next come "Head and Neck Cancer" (2,223) and "Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)" (1,782).

Most cited papers
#PaperReleasedCitations
1 A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Stephen Henry Friend, René Bernards, Snezna Rogelj et al. · Nature Open access Oct 1986 2,994
2 Head and Neck Cancer Everett E. Vokes, Ralph R. Weichselbaum, Scott Michael Lippman et al. · New England Journal of Medicine 21 Jan 1993 2,223
3 Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Jacques Bernier, Jay Scott Cooper, Thomas F. Pajak et al. · Head & Neck 2005 1,782
4 Nanoimprint lithography Stephen Y. Chou, Peter R. Krauss, Preston J. Renstrom · Journal of Vacuum Science & Technology B Microelectronics and Nanometer Structures Processing Measurement and Phenomena Nov 1996 1,723
5 Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip DAN E. ROWE, Raymond James Carroll, Calvin L. Day · Journal of the American Academy of Dermatology Jun 1992 1,520
All 100 most cited papers, with filters and sorting

Where is Ear and Head Tumors research done?

The largest centres of Ear and Head Tumors research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and New Delhi (India).

Largest cities, 2022-now

  1. 1 BeijingChina 56 works
  2. 2 TokyoJapan 55 works
  3. 3 ShanghaiChina 41 works
  4. 4 New DelhiIndia 37 works
  5. 5 SeoulSouth Korea 36 works
  6. 6 ChennaiIndia 25 works
  7. 7 HoustonUnited States 25 works
  8. 8 New YorkUnited States 25 works
  9. 9 IstanbulTürkiye 20 works
  10. 10 LondonUnited Kingdom 19 works
See Ear and Head Tumors on the map

Where is the best place to study Ear and Head Tumors?

Among universities, judged by research, Harvard University, Fudan University and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 14.05%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityCapital Medical Univ…Fudan UniversityAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 72.625.4%2.9×21 -32.1%
2Fudan UniversityChina 56.29.0%5.3×20 +64.1%
3All India Institute of Medical SciencesIndia 55.53.9%13.9×36 +52.6%
4Capital Medical UniversityChina 54.616.2%6.7×17 +34.5%
5University of MiamiUnited States 45.519.6%5.6×8 +7.9%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 43.815.4%5.5×14 +0.3%
7The Ohio State UniversityUnited States 43.217.4%3.5×10 +7.4%
8Emory UniversityUnited States 43.27.7%5.3×10 +62.9%
9University of California, Los AngelesUnited States 41.88.1%3.4×9 +42.8%
10Shanghai Jiao Tong UniversityChina 41.617.8%2.0×14 -17.1%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ear and Head Tumors, country by country

Is Ear and Head Tumors research growing?

Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ear and Head Tumors as a percentage of every work published that year, 0.012% in 2024.

still counting0.010%0.020%0.030%Ear and Head Tumors0.0094% in 202519801990200020102020

Fractional works of Ear and Head Tumors over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ear and Head Tumors10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ear and Head Tumors. Posts are plain text and can be reported.